{"id":202287,"name":"CAREDX","slug":"caredx","state":"CA","country":"United States of America","description":"molecular diagnostics company","totalSpending":704000,"filings":30,"yearlySpending":[{"year":2018,"income":0},{"year":2019,"income":150000},{"year":2020,"income":140000},{"year":2021,"income":50000},{"year":2022,"income":23000},{"year":2023,"income":141000},{"year":2024,"income":200000},{"year":2025,"income":0}],"issues":["HCR"],"firms":["CURA STRATEGIES"],"lobbyists":["SCOTT LEEZER","MICHAEL LISOWSKI","PATRICK MEADE","MATTHEW SIMMONS"],"govEntities":["Centers For Medicare and Medicaid Services (CMS)","Health & Human Services, Dept of (HHS)","HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Medicare coverage of immunosuppressive drugs for kidney transplant patients","Comprehensive immunosuppressive drug coverage for kidney transplant patients","Medicares discontinuation of coverage for immunosuppressive medication three years post-kidney transplant","Medicares discontinuation of coverage for immunosuppressive medication three years post-kidney transplant","Medicares discontinuation of coverage for immunosuppressive medication three years post-kidney transplant"],"years":[2018,2019,2020,2021,2022,2023,2024,2025]}